Holen Sie sich die Stockscreener-App
3.10
12.80%
-0.455
Finanzdaten der Dna X Inc-Aktie (SONM)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
64.68%
1.278
|
3.618 | -15.68 | 5.796 | 7.577 |
| Operating Income/Loss |
64.68%
-1.278
|
-3.618 | 4.661 | -3.98 | -6.732 |
| Income/Loss From Continuing Operations Before Tax |
68.48%
-1.238
|
-3.928 | 3.454 | -4.663 | -7.336 |
| Income Tax Expense/Benefit, Deferred |
110.52%
-0.263
|
2.499 | - | - | - |
| Income Tax Expense/Benefit |
109.57%
-0.243
|
2.538 | -1.507 | 0.09 | 0.139 |
| Income/Loss From Continuing Operations After Tax |
68.48%
-1.238
|
-3.928 | - | -4.753 | -7.475 |
| Income/Loss From Discontinued Operations, Net Of Tax |
100.09%
-0.009
|
10.27 | - | - | - |
| Net Income/Loss |
119.67%
-1.247
|
6.34 | -8.887 | -4.753 | -7.475 |
| Basic Average Shares |
6.79%
1.3509
|
1.2651 | - | 0.9849 | 9.5106 |
| Diluted Average Shares |
6.79%
1.3509
|
1.2651 | - | 0.9849 | 9.5106 |
| Basic Earnings Per Share |
118.36%
-0.92
|
5.01 | - | -4.83 | -0.79 |
| Diluted Earnings Per Share |
118.36%
-0.92
|
5.01 | - | -4.83 | -0.79 |
3.29%
16.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):